As progress continues in the Pradaxa multi district litigation (MDL), the bellwether case selection process has concluded with one of Doyle Raizner’s cases being chosen.
Boehringer Ingelheim Pharmaceuticals has issued a voluntary recall of 75-mg dose dabigatran (Pradaxa), citing a potential packaging defect.
NEW YORK (AP) — Boehringer Ingelheim said Wednesday it is recalling a single manufacturing lot of its anticlotting drug Pradaxa because the bottle may be defective.
Despite the recent advent of novel oral anticoagulants, the much-maligned warfarin remains the only current option available for patients who have received a mechanical valve.
TRENTON, N.J. — Johnson & Johnson said Friday that it has given the Food and Drug Administration additional data on its new anticlotting drug, in a second attempt to get approval for more uses.
Multi-district litigation over Pradaxa, a blood thinning medication, has grown to include 78 cases.
Doyle Raizner announces its support in the forming of a nationwide MDL, or multi-district litigation, formed to handle Pradaxa injury cases. With their experience they help people make the best decision about how and whether to proceed.
Houston area law firm Doyle Raizner is reaching out to people who have taken Pradaxa, an anti-coagulant prescription drug that’s proving to have potentially fatal side effects. The firm, which frequently represents medical patients and the elderly in lawsuits involving unsafe drugs, decided to take action after the drug’s high fatality rate came to light earlier this month.
Two new studies that attempted to evaluate whether the risk of bleeding from Pradaxa is greater than that of Warfarin came up with conflicting results.